Products for Research Use Only
RegisterLogin

Recombinant Human FGF23

CAT: 0171-Z100985Size: 20 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0171-Z100985Size:20 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
FGF-23 is a protein of ∼30 kDa that is proteolytically processed to generate smaller N-terminal (18 kDa) and C-terminal (12 kDa) fragments. The N-terminal fragment of FGF-23 contains the FGF receptor (FGFR)-binding domain. In vivo studies using synthetic peptides have indicated that neither of the processed N-terminal or C-terminal fragments of FGF-23 can influence serum phosphate levels. FGF-23 can decrease the activity of NaPi-2a and NaPi-2c cotransporters to reduce renal phosphate reabsorption and thereby can increase urinary phosphate excretion. Similarly, FGF-23 can suppress the expression of 1-alpha-hydroxylase to reduce the production of the active vitamin D metabolite 1,25(OH)2D. Moreover, FGF-23 can also induce 24- hydroxylase, which degrades 1,25(OH)2D
CAS Number
9000-83-3
Gene Name
FGF23
Gene Aliases
FGF-23, Phosphatonin, Tumor-derived hypophosphatemia-inducing factor, HYPF
Recombinant Human Fibroblast Growth Factor 23 (FGF23)
Gene ID
8074
Accession Number
Q9GZV9
Organism
Human
Source
E. coli
Concentration
<1.0 EU/μg of recombinant protein as determined by the LAL method.
Purity
>95% as determined by SDS-PAGE
Solubility
A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Function
The ED(50) was determined by the dose-dependent proliferation of mouse 3T3 cells expressing FGF receptors, and was found to be < 0.3 ug/mL, corresponding to a specific activity of 3.0 x 10^4 units/mg.
Molecular Weight
23
Shipping Conditions
Ambient Temperature
Storage Conditions
The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
Appearance
Lyophilized Powder
Formulation
Recombinant Human FGF23 was lyophilized from 0.2 μm filtered PBS solution, pH 7.4.

Related Products

CatalogName
20503051FGF23 Adenovirus (Human)
20503101FGF23 AAV Vector (Human) (CMV)
20503011FGF23 ORF Vector (Human) (pORF)
ORF004038FGF23 ORF Vector (Human) (pORF)
20503171FGF23 siRNA Oligos set (Human)
20503056FGF23 Adenovirus (Rat)
20503054FGF23 Adenovirus (Mouse)
K0779301FGF23 sgRNA CRISPR Lentivector set (Human)
K0779302FGF23 sgRNA CRISPR Lentivector (Human) (Target 1)
K0779303FGF23 sgRNA CRISPR Lentivector (Human) (Target 2)

Alternative Products

CatalogName
MBS4159720-01Recombinant Human FGF23
MBS1561688-01Recombinant Human FGF23 protein
PPT-12691Human FGF23 Recombinant Protein
E51P90577FGF23 protein, Human, Recombinant (His)
GR119216Genorise® Recombinant Human FGF23 protein
MBS1575266-01Recombinant Human FGF23, N-His
YR1427-01Anti-Human FGF23 Recombinant Antibody
HV625032-01Recombinant Human FGF23 Protein, N-His
EHJ53401Recombinant Human FGF23 Protein, C-His
OM300805-01FGF23 Human

Popular Products